BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Agnelli S, Gerra MC, Bignami E, Arendt-Nielsen L. Exosomes as a new pain biomarker opportunity. Mol Pain 2020;16:1744806920957800. [PMID: 32909507 DOI: 10.1177/1744806920957800] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Hosseini K, Ranjbar M, Pirpour Tazehkand A, Asgharian P, Montazersaheb S, Tarhriz V, Ghasemnejad T. Evaluation of exosomal non-coding RNAs in cancer using high-throughput sequencing. J Transl Med 2022;20:30. [PMID: 35033106 DOI: 10.1186/s12967-022-03231-y] [Reference Citation Analysis]
2 Hercher D, Nguyen MQ, Dworak H. Extracellular vesicles and their role in peripheral nerve regeneration. Exp Neurol 2021;350:113968. [PMID: 34973963 DOI: 10.1016/j.expneurol.2021.113968] [Reference Citation Analysis]
3 Diaz MM, Caylor J, Strigo I, Lerman I, Henry B, Lopez E, Wallace MS, Ellis RJ, Simmons AN, Keltner JR. Toward Composite Pain Biomarkers of Neuropathic Pain—Focus on Peripheral Neuropathic Pain. Front Pain Res 2022;3:869215. [DOI: 10.3389/fpain.2022.869215] [Reference Citation Analysis]
4 Boakye PA, Tang SJ, Smith PA. Mediators of Neuropathic Pain; Focus on Spinal Microglia, CSF-1, BDNF, CCL21, TNF-α, Wnt Ligands, and Interleukin 1β. Front Pain Res (Lausanne) 2021;2:698157. [PMID: 35295524 DOI: 10.3389/fpain.2021.698157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Dong J, Li L, Fang X, Zang M. Exosome-Encapsulated microRNA-127-3p Released from Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Osteoarthritis Through Regulating CDH11-Mediated Wnt/β-Catenin Pathway. J Pain Res 2021;14:297-310. [PMID: 33574696 DOI: 10.2147/JPR.S291472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Gerra MC, Dallabona C, Arendt-Nielsen L. Epigenetic Alterations in Prescription Opioid Misuse: New Strategies for Precision Pain Management. Genes (Basel) 2021;12:1226. [PMID: 34440400 DOI: 10.3390/genes12081226] [Reference Citation Analysis]
7 Lima TSM, Souza W, Geaquinto LRO, Sanches PL, Stepień EL, Meneses J, Fernández-de Gortari E, Meisner-Kober N, Himly M, Granjeiro JM, Ribeiro AR. Nanomaterial Exposure, Extracellular Vesicle Biogenesis and Adverse Cellular Outcomes: A Scoping Review. Nanomaterials (Basel) 2022;12:1231. [PMID: 35407349 DOI: 10.3390/nano12071231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 He F, Li L, Fan R, Wang X, Chen X, Xu Y. Extracellular Vesicles: An Emerging Regenerative Treatment for Oral Disease. Front Cell Dev Biol 2021;9:669011. [PMID: 34079801 DOI: 10.3389/fcell.2021.669011] [Reference Citation Analysis]
9 Yin B, Ni J, Witherel CE, Yang M, Burdick JA, Wen C, Wong SHD. Harnessing Tissue-derived Extracellular Vesicles for Osteoarthritis Theranostics. Theranostics 2022;12:207-31. [PMID: 34987642 DOI: 10.7150/thno.62708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 DiStefano TJ, Vaso K, Danias G, Chionuma HN, Weiser JR, Iatridis JC. Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory Considerations. Adv Healthc Mater 2022;11:e2100596. [PMID: 34297485 DOI: 10.1002/adhm.202100596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Balzani E, Fanelli A, Malafoglia V, Tenti M, Ilari S, Corraro A, Muscoli C, Raffaeli W. A Review of the Clinical and Therapeutic Implications of Neuropathic Pain. Biomedicines 2021;9:1239. [PMID: 34572423 DOI: 10.3390/biomedicines9091239] [Reference Citation Analysis]